Published in J Pharmacol Exp Ther on April 01, 1999
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure. Hypertension (2006) 1.52
Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department. Int J Emerg Med (2016) 0.75
Clinically Relevant Doses of Enalapril Mitigate Multiple Organ Radiation Injury. Radiat Res (2016) 0.75
Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology (1994) 5.00
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J (2003) 4.09
Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J (2003) 3.78
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J (2003) 2.78
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J (2002) 2.68
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet (2002) 2.61
One-year mortality among unselected outpatients with heart failure. Eur Heart J (2002) 2.30
Serum level monitoring of antibacterial drugs. A review. Clin Pharmacokinet (1985) 2.01
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation (1990) 1.98
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J (1999) 1.83
Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol (2000) 1.82
Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med (1988) 1.79
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol (1990) 1.76
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
Intravenous cyclosporine kinetics in renal failure. Clin Pharmacol Ther (1983) 1.73
Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension (1980) 1.69
Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol (1997) 1.62
Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation. Clin Pharmacol Ther (1982) 1.51
Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation (1993) 1.42
Economic assessment of tirofiban in the management of acute coronary syndromes in the hospital setting: an analysis based on the PRISM PLUS trial. Eur Heart J (1999) 1.41
Is blood pressure response to the Valsalva maneuver related to neurohormones, exercise capacity, and clinical findings in heart failure? Chest (1999) 1.40
Images in cardiovascular medicine. Idiopathic hypereosinophilic vasculitis. Circulation (1995) 1.39
Prognosis of medically treated patients referred for cardiac transplantation. Int J Cardiol (1998) 1.38
Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart (1999) 1.26
Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res (1997) 1.25
Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure. Circulation (1998) 1.22
Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. Am Rev Respir Dis (1982) 1.18
Calcium antagonists in hypertension. J Hypertens Suppl (1987) 1.18
Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. Int J Oral Maxillofac Surg (2002) 1.17
Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Br J Clin Pharmacol (1995) 1.16
Multicompartment pharmacokinetics of netilmicin. Eur J Clin Pharmacol (1979) 1.16
Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci (Lond) (1981) 1.14
Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol (1998) 1.12
Drug-induced pulmonary hypertension? Br Med J (1971) 1.12
The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol (1982) 1.11
Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation (2001) 1.10
Granulocyte-activating mediators (GRAM): I. Generation by lipopolysaccharide-stimulated mononuclear cells. J Invest Dermatol (1986) 1.09
Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction. Immunology (1990) 1.08
Influence of chronic dosing on theophylline clearance. Br J Clin Pharmacol (1985) 1.07
The vasodilator potency of atrial natriuretic peptide in man. Circulation (1987) 1.07
Hyperparathyroidism in congestive heart failure. Am J Med (1998) 1.07
Population pharmacokinetics of tobramycin. Br J Clin Pharmacol (1989) 1.07
Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipine. J Am Coll Cardiol (1986) 1.05
Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol (1996) 1.03
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Reliability of antiarrhythmic drug plasma concentration monitoring. Clin Pharmacokinet (1983) 1.00
Alpha 2 adrenoceptor-mediated vasoconstriction of arteries. Clin Pharmacol Ther (1983) 0.99
Heart valve replacement with St. Jude Medical valve prosthesis. Long-term experience in 743 patients in Switzerland. Circulation (1988) 0.99
Predicting individual phenytoin dosage. J Pharmacokinet Biopharm (1981) 0.98
Disulfide bridge conformers of mature BMP are inhibitors for heterotopic ossification. Biochem Biophys Res Commun (2001) 0.98
Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. Hypertension (1982) 0.97
Differently labelled glucosamine-precursor pools for the biosynthesis of hyaluronate and heparan sulfate. Eur J Biochem (1973) 0.96
Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine. Eur J Clin Pharmacol (1986) 0.96
Plasma concentration monitoring of aminoglycosides. J Antimicrob Chemother (1981) 0.95
O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA. Proc Natl Acad Sci U S A (1992) 0.95
Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol (1992) 0.95
Analysis of specific immunoglobulin G subclass antibodies for serological diagnosis of Echinococcosis by a standard enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1998) 0.95
Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man. Clin Sci (Lond) (1981) 0.95
Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol (1995) 0.95
LightCycler PCR assay for simultaneous detection of the H63D and S65C mutations in the HFE hemochromatosis gene based on opposite melting temperature shifts. Clin Chem (1999) 0.95
Temperature dependency of apparent cyclosporin A concentrations in plasma. Clin Chem (1983) 0.94
Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). Eur J Clin Pharmacol (1984) 0.94
Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance. Br J Clin Pharmacol (1979) 0.94
Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients. Am J Med (1984) 0.94
A comparison of cardiovascular effects of dobutamine and isoprenaline after open heart surgery. Br Heart J (1976) 0.93
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation (1994) 0.93
Factors influencing the hypotensive effects of calcium antagonists. Hypertension (1983) 0.92
Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol (1992) 0.92
Population pharmacokinetics of quinidine. Br J Clin Pharmacol (1991) 0.92
[Aortic valve insufficiency in Crohn disease]. Schweiz Med Wochenschr (1997) 0.91
Spontaneous multivessel coronary artery dissection in a pregnant woman treated successfully with stent implantation. Am J Med (1999) 0.91
Properties of the superoxide-generating oxidase of B-lymphocyte cell lines. Determination of Michaelis parameters. Biochem J (1989) 0.91
Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol (1987) 0.91
Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med (1998) 0.91
Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study. J Cardiovasc Pharmacol (1987) 0.91
Toxicity of amiodarone and amiodarone analogues on isolated rat liver mitochondria. J Hepatol (2001) 0.90
Interaction between amiodarone and lidocaine. J Cardiovasc Pharmacol (1996) 0.90
Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators. J Am Coll Cardiol (2000) 0.90
Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. J Cardiovasc Pharmacol (1985) 0.89
Serum concentration and antihypertensive effect of slow-release verapamil. J Cardiovasc Pharmacol (1982) 0.89
Cardiovascular effects of a new inotropic drug in dog and normal man. Clin Pharmacol Ther (1976) 0.89
Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab (1998) 0.89
Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects. Clin Exp Hypertens (1980) 0.89
Once a day verapamil in essential hypertension. Br J Clin Pharmacol (1986) 0.88
Induction of granulocyte chemiluminescence by a mediator derived from human monocytes. Lymphokine Res (1986) 0.88
Aortic valve replacement in elderly patients with aortic stenosis. Br Heart J (1994) 0.88
Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis (1996) 0.88
Influence of thyroid function on theophylline kinetics. Clin Pharmacol Ther (1984) 0.88
Primary angiosarcoma of the pulmonary arteries: dynamic contrast-enhanced MRI. J Comput Assist Tomogr (1998) 0.87